Results Snapshot
Figures in Cr
No Consolidated Results Declared by Dipna Pharmachem
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Jun 2026 is -16.48% vs 17.58% in Jun 2026
Standalone Net Profit
YoY Growth in nine months ended Jun 2026 is 146.58% vs -25.51% in Jun 2026
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Jun 2026 is 62.61% vs -8.37% in Jun 2026
Interest
YoY Growth in nine months ended Jun 2026 is -1.50% vs 12.71% in Jun 2026
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Jun 2026 has improved from Jun 2026
Compare Nine Monthly Results Of Dipna Pharmachem With
Figures in Cr
No Consolidated Results Declared by Dipna Pharmachem
Nine Monthly - Net Sales
Net Sales 92.66 Cr
in Jun 2026Figures in Cr
YoY Growth in nine months ended Jun 2026 is -16.48% vs 17.58% in Jun 2026
Nine Monthly - Standalone Net Profit
Standalone Net Profit 1.80 Cr
in Jun 2026Figures in Cr
YoY Growth in nine months ended Jun 2026 is 146.58% vs -25.51% in Jun 2026
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.74 Cr
in Jun 2026Figures in Cr
YoY Growth in nine months ended Jun 2026 is 62.61% vs -8.37% in Jun 2026
Nine Monthly - Interest
Interest 1.31 Cr
in Jun 2026Figures in Cr
YoY Growth in nine months ended Jun 2026 is -1.50% vs 12.71% in Jun 2026
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.84%
in Jun 2026Figures in %
YoY Growth in nine months ended Jun 2026 has improved from Jun 2026